Skip to content

Public FDA record

Z-0318-2008: Biomet Optigun Cement Gun, non-sterile; REF 419300 and REF 4193 (in Europe), Biomet, Inc., Warsaw, IN

Recall record Z-0318-2008 for Biomet, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0318-2008
Company in FDA record
Biomet, Inc.
FDA classification date
Dec 22, 2007
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Loose Screw Component: A screw may come loose and fall from the device during use, and result in implantation with the bone cement.

Source facts

Action
Consignees were notified via Urgent Medical Device Correction letter dated 9/21/07 to assure the screw components are fully seated and secure, to not use any guns with loose or missing screws, and to contact Biomet for instructions to return all instruments for evaluation and refurbishment.
Initiated
2007-09-21
Root cause
Device Design
Terminated
2009-06-30
Distribution
Worldwide: USA, Canada and Japan.
Recall number
Z-0318-2008
Recall status
Terminated
CDRH record ID
64477
FDA classified
2007-12-22
Recall event number
44892

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗